drugset
drugset / Trial / NCT04728308

Bupivacaine Infiltration and Postoperative Pain

NCT04728308 ↗

Phase 0 Unknown 300 enrolled Armed Forces Hospital, Pakistan
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a double-blind randomized controlled trial to assess the efficacy of local infiltration of bupivacaine versus placebo, in reducing postoperative pain. The severity of pain will be assessed in terms of mean score on visual analogue scale, opioid requirement and average duration of hospital stay.

Timeline

Start
2021-01-10
Primary completion
2021-04-10
Completion
2021-04-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.5 % Subcutaneous
Comparator Bupivacaine Other / unclassified 20 ml Subcutaneous

Indications

No indication recorded.